Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220018046 220009337 1.9 68 Curative (C) 2016-08-08 2016-09-24 EOX N N 220035292 BUSULFAN + FLUDARABINE + METHOTREXATE
220018047 220014955 1.5 51.3 Palliative (P) null 2014-01-28 ALL UKALL2011 Maintenance B1 null N 220035295 IPILIMUMAB
220018048 220009339 1.79 99.4 Palliative (P) 2014-02-08 2014-07-26 DOXORUBICIN N N 220035299 FCR
220018049 220014956 null null Curative (C) 2015-08-02 2015-08-20 LENALIDOMIDE N null 220035304 CYTARABINE + FLUDARABINE
220018050 220014956 1.65 null Curative (C) 2015-01-17 2015-01-17 Cisplatin + Radiotherapy N N 220035304 DOXORUBICIN
220018051 220021920 1.68 72.6 Curative (C) 2019-01-07 2019-01-07 CYTARABINE + FLUDARABINE 2 null 220035316 CYCLOPHOSPHAMIDE HIGH DOSE
220018052 220022310 1.63 84.9 Palliative (P) 2013-04-18 2013-04-25 ATG + BUSULFAN + CYCLOPHOSPHAMIDE N N 220035320 ARSENIC TRIOXIDE + ATRA
220018053 220009342 1.4 62 Palliative (P) 2015-08-18 2015-08-18 Ipilimumab 2 N 220035326 BUSULPHAN
220018054 220009344 1.61 80.5 Palliative (P) 2018-03-20 2018-03-20 Ipilimumab N N 220035327 LENALIDOMIDE
220018055 220009345 1.69 null Adjuvant (A) 2015-01-13 2015-02-18 Trifluridine + Tipiracil N N 220035329 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN
220018056 220014960 1.73 78.4 Not known (9) 2013-08-21 2013-08-21 ATG + Busulfan + Fludarabine + Thiotepa 2 N 220035332 VIDE
220018057 220014962 1.77 77.3 Curative (C) 2015-05-16 2015-05-28 PEMBROLIZUMAB N N 220035338 CARBOPLATIN
220018058 220014963 null 73.8 Disease modification (D) 2013-02-15 2013-04-03 LENALIDOMIDE N null 220035347 CYTARABINE IT + METHOTREXATE
220018061 220009358 1.49 58.9 Disease modification (D) 2014-11-15 2015-02-15 CYTARABINE + MITOXANTRONE N N 220035373 VINORELBINE
220018062 220009362 1.64 67.6 Palliative (P) 2017-06-03 2017-08-23 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE 2 null 220035392 VIDE
220018063 220009365 null 57.1 Curative (C) 2013-08-29 2013-08-29 CLOFARABINE + CYCLO + CYTARABINE + ETOP N N 220035399 GDCVP
220018064 220009366 null 51 Curative (C) 2016-01-21 2016-01-22 BUSULFAN + CYCLO null N 220035401 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220018065 220014971 1.63 87.2 Curative (C) 2016-09-14 2016-10-31 Capecitabine 02 N 220035406 MACE
220018066 220009370 null null Curative (C) 2016-01-24 2016-01-31 MITOXANTRONE + TRETINOIN N null 220035412 MELPHALAN
220018067 220009377 null null Palliative (P) 2013-12-17 2013-12-25 MACE null null 220035414 BUSULFAN + FLUDARABINE
220018068 220014974 1.83 108.5 null 2015-12-19 2015-12-19 CYTARABINE + MITOXANTRONE N N 220035417 FIGARO TRIAL
220018069 220009380 null 103.4 Curative (C) 2018-03-09 2018-04-08 Depocyte Intrathecal null null 220035428 ARSENIC TRIOXIDE + ATRA
220018071 220014976 1.75 null Neo-adjuvant (N) 2018-02-09 2018-03-23 ALL UKALL60+ TRIAL N N 220035451 MITOXANTRONE + TRETINOIN
220018072 220009387 null 90.5 Disease modification (D) 2017-08-12 2017-08-12 FLUDARABINE N N 220035454 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220018074 220021922 null null Palliative (P) 2014-06-13 2014-06-20 R IVAC N Y 220035488 SPANISH MAINTENANCE
220018075 220009395 null null Curative (C) 2017-07-19 2017-08-23 Methotrexate High Dose (3g/m2) Y N 220035492 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220018076 220009396 1.76 78.6 Curative (C) 2013-08-13 2013-12-11 ALL UKALL2011 Std BFM Cons B null N 220035497 ARSENIC TRIOXIDE + ATRA
220018077 220018178 null 76.6 null 2013-06-06 2013-06-09 MERCAPTOPURINE + METHOTREXATE 2 N 220035508 EOX
220018078 220009400 null 104.9 Not known (9) 2016-10-15 2016-10-15 CAP 2 N 220035535 FLUOROURACIL + IRINOTECAN + OXALIPLATIN
220018082 220009409 1.49 58 Curative (C) 2014-12-03 2015-01-03 CYTARABINE + MITOXANTRONE N N 220035549 FIGARO TRIAL
220018083 220014993 1.84 null null 2016-12-05 2016-12-14 INTERFERON N N 220035566 INTERFERON
220018085 220009417 1.68 75.1 Curative (C) 2018-03-05 2018-03-26 INTERFERON 2 N 220035600 ETOPOSIDE
220018086 220009419 1.51 55.2 Disease modification (D) 2015-02-19 2015-02-19 DABRAFENIB + TRAMETINIB Y N 220035603 CARBOPLATIN
220018087 220009422 1.67 79.2 Not known (9) 2015-03-18 2015-03-30 BUSULFAN + CYCLO N N 220035628 PEMBROLIZUMAB
220018088 220009422 1.75 69.1 Disease modification (D) 2014-08-28 2014-08-29 BUSULFAN + CYCLO Y N 220035628 BUSULPHAN + CYCLO
220018089 220009427 1.8 0 Curative (C) 2017-01-15 2017-01-27 MITOXANTRONE + TRETINOIN null N 220035638 UKALL 60+ TRIAL
220018090 220009427 null 39.2 Curative (C) 2016-07-05 2016-07-06 Bevacizumab+Carbo+Pacliaxel N N 220035638 NHL 2003
220018091 220009431 1.56 118.3 Curative (C) 2015-05-03 2015-05-29 Erlotinib 02 N 220035672 CARBOPLATIN + VINORELBINE
220018092 220018189 1.9 84 Curative (C) 2013-12-09 2013-12-09 Busulfan + Cyclophos Conditioning N N 220035685 CETUXIMAB + IRINOTECAN + MDG
220018093 220018189 null null Curative (C) 2018-02-01 2018-02-07 Methotrexate High Dose (3g/m2) null null 220035685 MITOXANTRONE + TRETINOIN
220018094 220009437 null 79.3 Curative (C) 2018-01-21 2018-01-21 CISPLATIN + ETOPOSIDE N N 220035738 VIOLA TRIAL
220018095 220009438 null 71.6 Curative (C) 2017-07-26 2017-07-26 CHLVPP N N 220035738 FLUDARABINE
220018097 220015008 null 87.1 Curative (C) 2018-03-11 2018-03-11 CAMELLIA Trial 2 N 220035765 CETUXIMAB
220018098 220009446 null null Not known (9) 2017-03-04 2017-03-21 AFATINIB N null 220035768 BEVACIZUMAB + CAPE + OXALIPLATIN
220018100 220009450 0 87.1 Disease modification (D) 2016-01-07 2016-10-07 ALL UKALL60+ TRIAL 02 N 220035793 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220018101 220009452 1.6 108 null 2014-03-20 2014-05-12 ALL UKALL2011 Std BFM Cons B 02 N 220035797 ARSENIC TRIOXIDE + ATRA
220018102 220018194 1.6 94 Disease modification (D) 2018-05-30 2018-09-14 Cetuximab+Cisplatin+FU (> Cycle 2) 2 null 220035808 CYTARABINE + MITOXANTRONE
220018103 220021599 1.69 81.3 null 2014-01-06 2014-01-18 Epirubicin N null 220035815 FLUDARABINE
220018104 220009454 null null Curative (C) 2016-02-06 2016-02-06 Methotrexate High Dose (3g/m2) 02 N 220035840 EOX
220018105 220009455 1.68 47.6 Palliative (P) 2013-10-31 2013-10-31 PEMBROLIZUMAB N N 220035846 FLUOROURACIL